Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
[This corrects the article DOI: 10.1155/2019/8035076.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088368 | PMC |
| http://dx.doi.org/10.1155/2021/9789181 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced states" [Neoplasia 66 (2025) 1101189].
Neoplasia
September 2025
Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Ange-les CA 90089, USA; Catherine & Joseph Aresty Department of Urology, Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA; Norris Comprehensiv
Corrigendum to "Quantitative dried blood spot microsampling for therapeutic drug monitoring of -antiseizure medications by design of experiment and UHPLC-MS/MS" [Talanta, Volume 293 (2025), 128018].
Talanta
September 2025
IRCCS Istituto delle Scienze Neurologiche di Bologna, Full Member of the European Reference Network for Rare and Complex Epilepsies (EpiCARE), Bologna, Italy.
Corrigendum to "Rapamycin and Starvation Mitigate Indomethacin-Induced Intestinal Damage through Preservation of Lysosomal Vacuolar ATPase Integrity": [The Journal of Pharmacology and Experimental Therapeutics 390 (2024) 108-115].
J Pharmacol Exp Ther
August 2025
Department of Pharmacology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan. Electronic address:
Corrigendum to "Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer" [Cancer Lett 448 (2019)182-196].
Cancer Lett
October 2025
Department of Chemistry and Purdue University Center for Cancer Research, 560 Oval Drive, West Lafayette, IN, 47907, USA. Electronic address:
[Corrigendum] Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma.
Int J Oncol
October 2025
Department of Oral and Maxillofacial Surgery, Ehime University Graduate School of Medicine, Toon, Ehime 791-0295, Japan.
Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that, regarding the western blots shown in Figs. 1C and 3A, the six lanes for the control β‑tubulin blots shown in Fig. 1C appeared strikingly similar to the β‑tubulin blots in Fig.
View Article and Find Full Text PDF